BridgeMD

Sign in

Bone Metastases clinical trials

Explore recruiting bone metastases clinical trials.

Recruiting bone metastases studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bone Metastases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Radium223 dichloride (223RaCl) in the treatment of symptomatic bone metastases from breast cancer.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Add-Aspirin: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non metastatic solid tumours.

Ireland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cabozantinib plus Durvalumab in patients with advanced and chemotherapy-treated bladder carcinoma, of urothelial and non-urothelial histology: an open-label, single-centre, phase 2, single-arm proof-of-concept trial: ARCADIA study

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Diagnostic Performance of Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Pre-operative Lymph Node Assessment in Intermediate and High-risk Nonmetastasic Prostate Cancer

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Multicentre, randomized, controlled, open-label, multi-centre medicoeconomic study evaluating the efficacy of adding zoledronic acid or denosumab to Stereotaxic radiotherapy in the treatment of vertebral metastases (ZOSTER)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Bone Metastases trials by city

Bone Metastases in Toronto Bone Metastases in Vancouver Bone Metastases in Montreal Bone Metastases in Calgary Bone Metastases in Edmonton Bone Metastases in Ottawa Bone Metastases in Winnipeg Bone Metastases in Quebec City Bone Metastases in Hamilton Bone Metastases in Kitchener Bone Metastases in London Bone Metastases in Halifax Bone Metastases in New York Bone Metastases in Los Angeles Bone Metastases in Chicago Bone Metastases in Houston